iSpecimen Inc (ISPC)
4.56
+0.30
(+7.04%)
USD |
NASDAQ |
Nov 19, 13:30
iSpecimen Revenue (TTM): 10.39M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.39M |
| June 30, 2024 | 10.51M |
| March 31, 2024 | 9.268M |
| December 31, 2023 | 9.928M |
| September 30, 2023 | 10.31M |
| June 30, 2023 | 10.12M |
| March 31, 2023 | 10.83M |
| December 31, 2022 | 10.40M |
| September 30, 2022 | 9.990M |
| Date | Value |
|---|---|
| June 30, 2022 | 10.12M |
| March 31, 2022 | 10.69M |
| December 31, 2021 | 11.14M |
| September 30, 2021 | 11.30M |
| June 30, 2021 | 10.84M |
| March 31, 2021 | 9.436M |
| December 31, 2020 | 8.184M |
| September 30, 2020 | 6.757M |
| June 30, 2020 | 5.199M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.199M
Minimum
Jun 2020
11.30M
Maximum
Sep 2021
9.746M
Average
10.22M
Median
Revenue (TTM) Benchmarks
| RadNet Inc | 1.773B |
| 23andMe Holding Co | 193.26M |
| Delcath Systems Inc | 22.64M |
| CytoSorbents Corp | 33.79M |
| Progyny Inc | 1.139B |